Journal of Cardiovascular Computed Tomography
Volume 3, Issue 4 , Pages 212-223 , July 2009

Outcomes Research in Cardiovascular Imaging: Report of a Workshop Sponsored by the National Heart, Lung, and Blood Institute

  • Pamela S. Douglas, MD

      Affiliations

    • Division of Cardiovascular Medicine, Duke University Medical Center, 7022 North Pavilion DUMC, PO Box 17969, Durham, North Carolina 27715, USA
    • Corresponding Author InformationCorresponding author.
    • ,
  • Allen Taylor, MD

      Affiliations

    • Department of Medicine, Cardiovascular Research Institute, Washington Hospital Center, Washington, DC
    • ,
  • Diane Bild, MD

      Affiliations

    • Division of Prevention and Population Sciences and, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Robert Bonow, MD

      Affiliations

    • Northwestern University Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Philip Greenland, MD

      Affiliations

    • Northwestern University Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Michael Lauer, MD

      Affiliations

    • Division of Cardiovascular Sciences, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Frank Peacock, MD

      Affiliations

    • Emergency Medicine, Cleveland Clinic, Cleveland, Ohio
    • ,
  • James Udelson, MD

      Affiliations

    • Division of Cardiology, Tufts Medical Center, Boston, Massachusetts

Received 23 October 2008 ,Accepted 23 January 2009.

References 

  1. Di Carli M, Hachamovitch R. New technology for noninvasive evaluation of coronary artery disease. Circulation. 2007;115:1464–1480
  2. Demaria AN. The growth of diagnostic imaging services. J Am Coll Cardiol. 2005;45:2093–2094
  3. Lucas FL, DeLorenzo MA, Siewers AE, Wennberg DE. Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993–2001. Circulation. 2006;113:374–379
  4. U.S. Government Accountability Office. Medicare Part B Imaging Services: Rapid Spending Growth and Shift to Physician Offices Indicate Need for CMS to Consider Additional Management Practices. Available at: http://www/gao.gov/news.items/d08452.pdf. Accessed August 16, 2008.
  5. Wennberg DE, Kellett MA, Dickens JD, Malenka DJ, Keilson LM, Keller RB. The association between local diagnostic testing intensity and invasive cardiac procedures. JAMA. 1996;275:1161–1164
  6. Shah BR, Patel MR, Peterson ED, Douglas PS. Defining optimal research study design for cardiovascular imaging using computed tomography angiography as a model. Am J Cardiol. 2008;102:943–948
  7. Redberg RF. Computed tomographic angiography: more than just a pretty picture?. J Am Coll Cardiol. 2007;49:1827–1829
  8. Einstein AJ, Henzlova MJ, Rajagopalan S. Estimating risk of cancer associated with radiation exposure from 64-slice computed tomography coronary angiography. JAMA. 2007;298:317–323
  9. Brenner DJ, Hall EJ. Computed tomography—an increasing source of radiation exposure. N Engl J Med. 2007;357:2277–2284
  10. Levin DC, Rao VM. Turf wars in radiology: updated evidence on the relationship between self-referral and the overutilization of imaging. J Am Coll Radiol. 2008;5:806–810
  11. Lee TH, Brennan TA. Direct-to-consumer marketing of high-technology screening tests. N Engl J Med. 2002;346:529–531
  12. Gazelle GS, McMahon PM, Siebert U, Beinfeld MT. Cost-effectiveness analysis in the assessment of diagnostic imaging technologies. Radiology. 2005;235:361–370
  13. Soman P, Udelson JE. The price for probability: comparing the costs of diagnostic testing strategies. J Nucl Cardiol. 2007;14:142–144
  14. Fryback DG, Thornbury JR. The efficacy of diagnostic imaging. Med Decis Making. 1991;11:88–94
  15. Douglas PS, Iskandrian AE, Krumholz HM, et al. Achieving quality in cardiovascular imaging: proceedings from the American College of Cardiology-Duke University Medical Center Think Tank on Quality in Cardiovascular Imaging. J Am Coll Cardiol. 2006;48:2141–2151
  16. Douglas PS. Improving imaging: our professional imperative. J Am Coll Cardiol. 2006;2152–2153
  17. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002;359:909–919
  18. Medicine Marshall E. A bruising battle over lung scans. Science. 2008;320:600–603
  19. Patz EF, Goodman PC, Bepler G. Screening for lung cancer. N Engl J Med. 2000;343:1627–1633
  20. Schilling FH, Spix C, Berthold F, et al. Neuroblastoma screening at one year of age. N Engl J Med. 2002;346:1047–1053
  21. Lord SJ, Irwig L, Simes RJ. When is measuring sensitivity and specificity sufficient to evaluate a diagnostic test, and when do we need randomized trials?. Ann Intern Med. 2006;144:850–855
  22. Siebelink HM, Blanksma PK, Crijns HJ, et al. No difference in cardiac event-free survival between positron emission tomography-guided and single-photon emission computed tomography-guided patient management: a prospective, randomized comparison of patients with suspicion of jeopardized myocardium. J Am Coll Cardiol. 2001;37:81–88
  23. The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN [TCT00282711]. Available at: www.clinicaltrials.gov. Accessed August 24, 2008.
  24. Nallamothu BK, Hayward RA, Bates ER. Beyond the randomized clinical trial: the role of effectiveness studies in evaluating cardiovascular therapies. Circulation. 2008;118:1294–1303
  25. Stowers SA, Eisenstein EL, Th Wackers FJ, et al. An economic analysis of an aggressive diagnostic strategy with single photon emission computed tomography myocardial perfusion imaging and early exercise stress testing in emergency department patients who present with chest pain but nondiagnostic electrocardiograms: results from a randomized trial. Ann Emerg Med. 2000;35:17–25
  26. Udelson JE, Beshansky JR, Ballin DS, et al. Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. JAMA. 2002;288:2693–2700
  27. National Heart, Lung, and Blood Institute. Shaping the future of research. Available at: http://apps.nhlbi.nih.gov/strategicplan/StrategicPlan̲Appendix.pdf. Accessed May 11, 2009.
  28. Wilson JM. The evaluation of the worth of early disease detection. J R Coll Gen Pract. 1968;16(Suppl 2):48–57
  29. Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet. 2002;360:1531–1539
  30. Scott R, Ashton H, Kay D. Routine ultrasound screening in management of abdominal aortic aneurysms. Br Med J. 1988;296:1709–1710
  31. Scott R, Bridgewater S, Ashton H. Randomized clinical trial of screening for abdominal aortic aneurysm in women. Br J Surg. 2002;89:283–285
  32. Mosca L, Banka CL, Benjamin EJ, et al. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation. 2007;115:1481–1501
  33. Waugh N, Black C, Walker S, McIntyre L, Cummins E, Hillis G. The effectiveness and cost-effectiveness of computed tomography screening for coronary artery disease: systematic review. Health Technol Assess. 2006;10:iii–iivix–x, 1–41
  34. Greenland P, Lloyd-Jones D. Defining a rational approach to screening for cardiovascular risk in asymptomatic patients. J Am Coll Cardiol. 2008;52:330–332
  35. Cohn JN, Duprez DA. Time to foster a rational approach to preventing cardiovascular morbid events. J Am Coll Cardiol. 2008;52:327–329
  36. Naghavi M, Falk E, Hecht HS, et al. From vulnerable plaque to vulnerable patient part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol. 2006;98:2H–15H
  37. Greenland P, Bonow RO, Brundage BH, et al. on behalf of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) Society of Atherosclerosis Imaging and Prevention; Society of Cardiovascular Computed Tomography. ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). J Am Coll Cardiol. 2007;49:378–402
  38. Detrano R, Guerci AD, Carr JJ, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–1345
  39. Budoff MJ, Achenbach S, Blumenthal RS, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation. 2006;114:1761–1791
  40. Stein JH, Korcarz CE, Hurst RT, et al. on behalf of American Society of Echocardiography Carotid Intima-Media Thickness Task Force Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the Society for Vascular Medicine. J Am Soc Echocardiogr. 2008;21:93–111
  41. Folsom AR, Kronmal RA, Detrano RC, et al. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med. 2008;168:1333–1339
  42. Lauer MS. Screening for coronary heart disease: has the time for universal imaging arrived?. Cleve Clin J Med. 2007;74:645–656
  43. Wald NJ. Screening: a step too far. A matter of concern. J Med Screen. 2007;14:163–164
  44. Klocke FJ, Baird MG, Lorell BH, et al. on behalf of American College of Cardiology American Heart Association Task Force on Practice Guidelines; American Society for Nuclear Cardiology. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). J Am Coll Cardiolg. 2003;42:1318–1333
  45. Cheitlin MD, Alpert JS, Armstrong WF, et al. ACC/AHA guidelines for the clinical application of echocardiography. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography). Developed in collaboration with the American Society of Echocardiography. J Am Coll Cardiol. 1997;29:862–879
  46. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation. 1996;93:905–914
  47. Gibbons RJ, Hodge DO, Berman DS, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation. 1999;100:2140–2145
  48. Bangalore S, Gopinath D, Yao SS, Chaudhry FA. Risk stratification using stress echocardiography: incremental prognostic value over historic, clinical, and stress electrocardiographic variables across a wide spectrum of Bayesian pretest probabilities for coronary artery disease. J Am Soc Echocardiogr. 2007;20:244–252
  49. Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000;342:1163–1170
  50. Han JH, Lindsell CJ, Storrow AB, et al. The role of cardiac risk factor burden in diagnosing acute coronary syndromes in the emergency department setting. Ann Emerg Med. 2007;49:145–152152e1
  51. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000;284:835–842
  52. Canto JG, Shlipak MG, Rogers WJ, et al. Prevalence, clinical characteristics, and mortality among patients with myocardial infarction presenting without chest pain. JAMA. 2000;283:3223–3229
  53. Peacock WI, Emerman CL, McErlean ES, et al. Prediction of short- and long-term outcomes by troponin T levels in low-risk patients evaluated for acute coronary syndromes. Ann Emerg Med. 2000;35:213–220
  54. Kugelmass AD, Anderson AL, Brown PP. Does having a chest pain center impact the treatment and survival of acute myocardial infarction patients (abstr)?. Circulation. 2004;110:III409
  55. Mitchell AM, Garvey JL, Chandra A, Diercks D, Pollack CV, Kline JA. Prospective multicenter study of quantitative pretest probability assessment to exclude acute coronary syndrome for patients evaluated in emergency department chest pain units. Ann Emerg Med. 2006;47:447
  56. Reilly BM, Evans AT, Schaider JJ, Wang Y. Triage of patients with chest pain in the emergency department: a comparative study of physicians' decisions. Am J Med. 2002;112:95–103
  57. Freas GC. Medicolegal aspects of acute myocardial infarction. Emerg Med Clin North Am. 2001;19:511–521
  58. Pilote L, Granger C, Armstrong PW, Mark DB, Hlatky MA. Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial. Med Care. 1995;33:598–610
  59. Graff LG, Dallara J, Ross MA, et al. Impact on the care of the emergency department chest pain patient from the chest pain evaluation registry (CHEPER) study. Am J Cardiol. 1997;80:563–568
  60. Bluemke DA, Achenbach S, Budoff M, et al. Noninvasive coronary artery imaging: magnetic resonance angiography and multidetector computed tomography angiography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention of the Council on Cardiovascular Radiology and Intervention, and the Councils on Clinical Cardiology and Cardiovascular Disease in the Young. Circulation. 2008;118:586–606
  61. Bonow RO. Identification of viable myocardium. Circulation. 1996;94:2674–2680
  62. Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol. 2007;32:375–410
  63. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of myocardial viability. Circulation. 2008;117:103–114
  64. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol. 2002;39:1151–1158
  65. Velazquez EJ, Lee KL, O'Connor CM, et al. on behalf of STICH Investigators The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial. J Thorac Cardiovasc Surg. 2007;134:1540–1547
  66. Bursi F, Enriquez-Sarano M, Nkomo VT, et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation. 2005;111:295–301
  67. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759–1764
  68. Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation. 2005;112:745–758
  69. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45:381–387
  70. Mehra MR, Gheorghiade M, Bonow RO. Mitral regurgitation in chronic heart failure: more questions than answers?. Curr Cardiol Rep. 2004;6:96–99

 Dr. Taylor has received research grant support (without salary compensation) and educational honoraria from Abbott Labs for the topic of HDL cholesterol and prevention. Dr. Greenland served as a consultant to GE and Toshiba, and received a small honorarium from Pfizer for a role on a Visiting Professor Selection Committee. Dr. Peacock is on the Scientific Advisory Board, or is a consultant or speaker for Abbott, Beckman Coulter, Biosite, Heartscape, Inovise, Inverness, Ortho Clinical Diagnostics, and The Medicines Company. He has received research grants from Abbott, BAS, Biosite, Brahms, Heartscape, Inovise, Inverness, EKR, and The Medicines Company. Also, he has an ownership interest in Vital Sensors. Dr. Udelson is co-PI of the ROMICAT-2 trial, sponsored by the American College of Radiology Imaging Network (ACRIN). He has received research funding and has served as a consultant to Lantheus Medical Imaging and Molecular Insight Pharmaceuticals. Drs. Douglas and Taylor are co-first authors. Reviewers for this article are: Stephan Achenbach, MD, Associate Editor, JACC: Cardiovascular Imaging; Thomas Marwick, MBBS, PhD, Associate Editor, JACC: Cardiovascular Imaging; Christopher Kramer, MD, Associate Editor, JACC: Cardiovascular Imaging; Vasken Dilsizian, MD, Associate Editor, JACC: Cardiovascular Imaging.

PII: S1934-5925(09)00252-4

doi: 10.1016/j.jcct.2009.06.001

Journal of Cardiovascular Computed Tomography
Volume 3, Issue 4 , Pages 212-223 , July 2009

Article Tools

* Image Usage & Resolution